Nurulimab, CAS 2168561-20-2

Product Description: Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 34, No. 1, 2020.

CAS Number: 2168561-20-2

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CTLA-4

• Artikelnummer: MEXHY-P99760-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99760-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated